UCBJY:OTCMKTS
UCB
114,46 USD
arrow_downward
−0,87%(−1,01) 1D
16. lis, 16:00:00 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za UCBJY...
Otvori
114,95 USD
Najviša
115,28 USD
Najniža
114,23 USD
Trž. kap.
39,39 mlr.
Prosj. kol.
53,31 tis.
Količina
70,57 tis.
52-tjed. najviša
168,76 USD
52-tjed. najniža
110,55 USD
Beta
0,57
Dionice u optjecaju
389,01 mil.
Broj djelatnika
9 tis.
Otvori
114,95 USD
Najviša
115,28 USD
Najniža
114,23 USD
Trž. kap.
39,39 mlr.
Prosj. kol.
53,31 tis.
Količina
70,57 tis.
52-tjed. najviša
168,76 USD
52-tjed. najniža
110,55 USD
Beta
0,57
Dionice u optjecaju
389,01 mil.
Broj djelatnika
9 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 1 dan
UCB launches Wear It Out: what it means for UCB stock
Profil
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
UCB – informacije
Glavni izvršni direktorJean-Christophe Tellier
Zaposlenici9 tis.
Osnovano18. sij 1928.
Sjedište-
Sektor-
Web-lokacijaucb.com